SmithKline Beecham Engerix-B
Executive Summary
FDA approves hepatitis B vaccine Aug. 13 for use in patients with chronic hepatitis C infection. In a trial of patients with chronic hepatitis C who were administered Engerix-B on a 0, 1, and 6 month schedule, all patients responded with seroprotective titers, the company said